Military Airborne Collision Avoidance Systems
Military Airborne Collision Avoidance Systems market is segmented by players, region (country), b ... Read More
Global Migraine Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injectable
1.2.4 Nasal Sprays
1.2.5 Others
1.3 Market by Application
1.3.1 Global Migraine Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Migraine Market Perspective (2017-2028)
2.2 Migraine Growth Trends by Region
2.2.1 Migraine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Migraine Historic Market Size by Region (2017-2022)
2.2.3 Migraine Forecasted Market Size by Region (2023-2028)
2.3 Migraine Market Dynamics
2.3.1 Migraine Industry Trends
2.3.2 Migraine Market Drivers
2.3.3 Migraine Market Challenges
2.3.4 Migraine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Migraine Players by Revenue
3.1.1 Global Top Migraine Players by Revenue (2017-2022)
3.1.2 Global Migraine Revenue Market Share by Players (2017-2022)
3.2 Global Migraine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Migraine Revenue
3.4 Global Migraine Market Concentration Ratio
3.4.1 Global Migraine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine Revenue in 2021
3.5 Migraine Key Players Head office and Area Served
3.6 Key Players Migraine Product Solution and Service
3.7 Date of Enter into Migraine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Breakdown Data by Type
4.1 Global Migraine Historic Market Size by Type (2017-2022)
4.2 Global Migraine Forecasted Market Size by Type (2023-2028)
5 Migraine Breakdown Data by Application
5.1 Global Migraine Historic Market Size by Application (2017-2022)
5.2 Global Migraine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Migraine Market Size (2017-2028)
6.2 North America Migraine Market Size by Country (2017-2022)
6.3 North America Migraine Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Migraine Market Size (2017-2028)
7.2 Europe Migraine Market Size by Country (2017-2022)
7.3 Europe Migraine Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Migraine Market Size (2017-2028)
8.2 Asia-Pacific Migraine Market Size by Country (2017-2022)
8.3 Asia-Pacific Migraine Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Migraine Market Size (2017-2028)
9.2 Latin America Migraine Market Size by Country (2017-2022)
9.3 Latin America Migraine Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Migraine Market Size (2017-2028)
10.2 Middle East & Africa Migraine Market Size by Country (2017-2022)
10.3 Middle East & Africa Migraine Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Migraine Introduction
11.1.4 Pfizer Revenue in Migraine Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Migraine Introduction
11.2.4 GlaxoSmithKline Revenue in Migraine Business (2017-2022)
11.2.5 GlaxoSmithKline Recent Development
11.3 Allergan
11.3.1 Allergan Company Detail
11.3.2 Allergan Business Overview
11.3.3 Allergan Migraine Introduction
11.3.4 Allergan Revenue in Migraine Business (2017-2022)
11.3.5 Allergan Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Migraine Introduction
11.4.4 Amgen Revenue in Migraine Business (2017-2022)
11.4.5 Amgen Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Migraine Introduction
11.5.4 Eli Lilly Revenue in Migraine Business (2017-2022)
11.5.5 Eli Lilly Recent Development
11.6 Teva Pharma
11.6.1 Teva Pharma Company Detail
11.6.2 Teva Pharma Business Overview
11.6.3 Teva Pharma Migraine Introduction
11.6.4 Teva Pharma Revenue in Migraine Business (2017-2022)
11.6.5 Teva Pharma Recent Development
11.7 Biohaven Pharma
11.7.1 Biohaven Pharma Company Detail
11.7.2 Biohaven Pharma Business Overview
11.7.3 Biohaven Pharma Migraine Introduction
11.7.4 Biohaven Pharma Revenue in Migraine Business (2017-2022)
11.7.5 Biohaven Pharma Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Migraine Introduction
11.8.4 Abbott Laboratories Revenue in Migraine Business (2017-2022)
11.8.5 Abbott Laboratories Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Migraine Introduction
11.9.4 Johnson & Johnson Revenue in Migraine Business (2017-2022)
11.9.5 Johnson & Johnson Recent Development
11.10 Valeant Pharma
11.10.1 Valeant Pharma Company Detail
11.10.2 Valeant Pharma Business Overview
11.10.3 Valeant Pharma Migraine Introduction
11.10.4 Valeant Pharma Revenue in Migraine Business (2017-2022)
11.10.5 Valeant Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Migraine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Key Players of Nasal Sprays
Table 5. Key Players of Others
Table 6. Global Migraine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Migraine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Migraine Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Migraine Market Share by Region (2017-2022)
Table 10. Global Migraine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Migraine Market Share by Region (2023-2028)
Table 12. Migraine Market Trends
Table 13. Migraine Market Drivers
Table 14. Migraine Market Challenges
Table 15. Migraine Market Restraints
Table 16. Global Migraine Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Migraine Market Share by Players (2017-2022)
Table 18. Global Top Migraine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine as of 2021)
Table 19. Ranking of Global Top Migraine Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Migraine Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Migraine Product Solution and Service
Table 23. Date of Enter into Migraine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Migraine Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Migraine Revenue Market Share by Type (2017-2022)
Table 27. Global Migraine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Migraine Revenue Market Share by Type (2023-2028)
Table 29. Global Migraine Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Migraine Revenue Market Share by Application (2017-2022)
Table 31. Global Migraine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Migraine Revenue Market Share by Application (2023-2028)
Table 33. North America Migraine Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Migraine Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Migraine Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Migraine Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Migraine Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Migraine Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Migraine Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Migraine Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Migraine Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Migraine Market Size by Country (2023-2028) & (US$ Million)
Table 43. Pfizer Company Detail
Table 44. Pfizer Business Overview
Table 45. Pfizer Migraine Product
Table 46. Pfizer Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 47. Pfizer Recent Development
Table 48. GlaxoSmithKline Company Detail
Table 49. GlaxoSmithKline Business Overview
Table 50. GlaxoSmithKline Migraine Product
Table 51. GlaxoSmithKline Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 52. GlaxoSmithKline Recent Development
Table 53. Allergan Company Detail
Table 54. Allergan Business Overview
Table 55. Allergan Migraine Product
Table 56. Allergan Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 57. Allergan Recent Development
Table 58. Amgen Company Detail
Table 59. Amgen Business Overview
Table 60. Amgen Migraine Product
Table 61. Amgen Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 62. Amgen Recent Development
Table 63. Eli Lilly Company Detail
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Migraine Product
Table 66. Eli Lilly Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Teva Pharma Company Detail
Table 69. Teva Pharma Business Overview
Table 70. Teva Pharma Migraine Product
Table 71. Teva Pharma Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 72. Teva Pharma Recent Development
Table 73. Biohaven Pharma Company Detail
Table 74. Biohaven Pharma Business Overview
Table 75. Biohaven Pharma Migraine Product
Table 76. Biohaven Pharma Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 77. Biohaven Pharma Recent Development
Table 78. Abbott Laboratories Company Detail
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Migraine Product
Table 81. Abbott Laboratories Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 82. Abbott Laboratories Recent Development
Table 83. Johnson & Johnson Company Detail
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Migraine Product
Table 86. Johnson & Johnson Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Valeant Pharma Company Detail
Table 89. Valeant Pharma Business Overview
Table 90. Valeant Pharma Migraine Product
Table 91. Valeant Pharma Revenue in Migraine Business (2017-2022) & (US$ Million)
Table 92. Valeant Pharma Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Migraine Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. Nasal Sprays Features
Figure 5. Others Features
Figure 6. Global Migraine Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Home Care Case Studies
Figure 10. Migraine Report Years Considered
Figure 11. Global Migraine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Migraine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Migraine Market Share by Region: 2021 VS 2028
Figure 14. Global Migraine Market Share by Players in 2021
Figure 15. Global Top Migraine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Migraine Revenue in 2021
Figure 17. North America Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Migraine Market Share by Country (2017-2028)
Figure 19. United States Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Migraine Market Share by Country (2017-2028)
Figure 23. Germany Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Migraine Market Share by Region (2017-2028)
Figure 31. China Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Migraine Market Share by Country (2017-2028)
Figure 39. Mexico Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Migraine Market Share by Country (2017-2028)
Figure 43. Turkey Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Migraine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Migraine Business (2017-2022)
Figure 46. GlaxoSmithKline Revenue Growth Rate in Migraine Business (2017-2022)
Figure 47. Allergan Revenue Growth Rate in Migraine Business (2017-2022)
Figure 48. Amgen Revenue Growth Rate in Migraine Business (2017-2022)
Figure 49. Eli Lilly Revenue Growth Rate in Migraine Business (2017-2022)
Figure 50. Teva Pharma Revenue Growth Rate in Migraine Business (2017-2022)
Figure 51. Biohaven Pharma Revenue Growth Rate in Migraine Business (2017-2022)
Figure 52. Abbott Laboratories Revenue Growth Rate in Migraine Business (2017-2022)
Figure 53. Johnson & Johnson Revenue Growth Rate in Migraine Business (2017-2022)
Figure 54. Valeant Pharma Revenue Growth Rate in Migraine Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer GlaxoSmithKline Allergan Amgen Eli Lilly Teva Pharma Biohaven Pharma Abbott Laboratories Johnson & Johnson Valeant Pharma